Recipient Epidemiology and Donor Evaluation Study-III | NHLBI Trans-Omics for Precision Medicine Skip to main content

Recipient Epidemiology and Donor Evaluation Study-III

Short Name
REDS-III_Brazil
Institution(s)
Vitalant Research Institute
Type of Omics
WGS
Approx. Sample Size 2809
Disease/Phenotype
sickle cell disease
Starting Phase
Phase 2
TOPMed Accession #
phs001468
Omics Center(s) Phase 2
Baylor College of Medicine Human Genome Sequencing Center
Specify the TOPMed Phase for the Omics Center(s) selected above
5.4
Omics Center Contact
Phases Involved
2
Populations
Brazilian
PI
Co-PI
Phenotype Liaison
Data Set contact(s)
COL Contact(s)
Project
REDS-III_Brazil
Back to top